Neurolutions

Understand the key differences and benefits of orthoses and therapeutic devices in aiding stroke survivors.

Deciphering stroke impacts: Comparing the varying effects of strokes on the left versus the right side of the brain.

The page covers the risks, symptoms, and treatments of brain bleeds and strokes, as well as strategies for maintaining brain health.

The page discusses Brain-Computer Interface (BCI) technology in stroke rehabilitation and patient recovery.

Eric C. Leuthardt, M.D., is a neurosurgeon whose research focuses on neuroprosthetics, brain-linked devices that may lead to cures for paralysis, enable patients to move artificial limbs, or restore other neurological functions.

The page covers Neurolutions' progress in supporting stroke survivor recovery and brain-computer interface technology.

Dr. Eric Leuthardt is a neurosurgeon at Washington University in St. Louis who discusses neural prosthetics and future scenarios depicted in science fiction.

IpsiHand is an FDA-cleared non-invasive therapy for rehabilitation of upper extremity motor function after stroke.

Neurolutions offers the IpsiHand system.

Neurolutions utilizes s powered by one’s own thoughts using brain-computer interface to aid in stroke recovery and help survivors regain their independence.

Neurolutions’ IpsiHand® demonstrates clinically meaningful improvement in upper extremity motor function for stroke patients in a post-market randomized study. The trial compares outcomes against usual care, confirming efficacy in vascular and interventional neurology. Results are published in *Stroke*, validating the brain-computer interface (BCI) technology’s potential for rehabilitation.

Aug 2026NeurolutionsNews article

Neurolutions’ FDA-cleared brain-computer interface **IpsiHand®** shows clinically meaningful improvements in upper extremity motor function for chronic stroke patients in a post-market randomized controlled trial. The study compares outcomes against usual care, highlighting its potential as a rehabilitation tool. Results indicate measurable progress in motor recovery for participants using the system.

Feb 2026NeurolutionsNews article

Dr. Eric Leuthardt presents randomized controlled trial results for **IpsiHand®**, Kandu’s FDA-cleared brain-computer interface device. The study assesses the device’s clinical performance in stroke patients. Findings will be shared at the **International Stroke Conference 2026**.

Feb 2026NeurolutionsNews article

Kandu, Inc. emerges from the merger of Kandu Health and Neurolutions, positioning itself as a leader in **at-home stroke recovery and rehabilitation**. The company secures **$30 million in financing** to expand its digital care solutions for patients and caregivers. The integration aims to redefine stroke recovery standards through accessible, home-based therapies.

Apr 2025NeurolutionsNews article